» Articles » PMID: 26998266

XB130: A Novel Adaptor Protein in Cancer Signal Transduction

Overview
Journal Biomed Rep
Specialty Biochemistry
Date 2016 Mar 22
PMID 26998266
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Adaptor proteins are functional proteins that contain two or more protein-binding modules to link signaling proteins together, which affect cell growth and shape and have no enzymatic activity. The actin filament-associated protein (AFAP) family is an important member of the adaptor proteins, including AFAP1, AFAP1L1 and AFAP1L2/XB130. AFAP1 and AFAP1L1 share certain common characteristics and function as an actin-binding protein and a cSrc-activating protein. XB130 exhibits certain unique features in structure and function. The mRNA of XB130 is expressed in human spleen, thyroid, kidney, brain, lung, pancreas, liver, colon and stomach, and the most prominent disease associated with XB130 is cancer. XB130 has a controversial effect on cancer. Studies have shown that XB130 can promote cancer progression and downregulation of XB130-reduced growth of tumors derived from certain cell lines. A higher mRNA level of XB130 was shown to be associated with a better survival in non-small cell lung cancer. Previous studies have shown that XB130 can regulate cell growth, migration and invasion and possibly has the effect through the cAMP-cSrc-phosphoinositide 3-kinase/Akt pathway. Except for cancer, XB130 is also associated with other pathological or physiological procedures, such as airway repair and regeneration.

Citing Articles

Integrated proteogenomic characterization of ampullary adenocarcinoma.

Zhang Q, Xu X, Jiang D, Wang Y, Wang H, Zhu J Cell Discov. 2025; 11(1):2.

PMID: 39762212 PMC: 11704194. DOI: 10.1038/s41421-024-00742-4.


Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer.

Li Z, Zhao H, Hu H, Shang H, Ren Y, Qiu W Chin J Cancer Res. 2024; 36(3):306-321.

PMID: 38988489 PMC: 11230884. DOI: 10.21147/j.issn.1000-9604.2024.03.07.


Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy.

Ma Z, Chen W, Liu Y, Yu L, Mao X, Guo X Autophagy. 2023; 20(3):541-556.

PMID: 37733919 PMC: 10936616. DOI: 10.1080/15548627.2023.2261758.


The 3'‑untranslated region of XB130 regulates its mRNA stability and translational efficiency in non‑small cell lung cancer cells.

Wang Q, Liu L, Gou X, Zhang T, Zhao Y, Xie Y Oncol Lett. 2023; 26(4):427.

PMID: 37720672 PMC: 10502931. DOI: 10.3892/ol.2023.14013.


AFAP1L1 promotes gastric cancer progression by interacting with VAV2 to facilitate CDC42-mediated activation of ITGA5 signaling pathway.

Sun B, Ding B, Chen Y, Peng C, Chen X J Transl Med. 2023; 21(1):18.

PMID: 36631800 PMC: 9835296. DOI: 10.1186/s12967-023-03871-8.


References
1.
Dawson M, Prinjha R, Dittmann A, Giotopoulos G, Bantscheff M, Chan W . Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature. 2011; 478(7370):529-33. PMC: 3679520. DOI: 10.1038/nature10509. View

2.
Zuiderweg E . Mapping protein-protein interactions in solution by NMR spectroscopy. Biochemistry. 2002; 41(1):1-7. DOI: 10.1021/bi011870b. View

3.
Xing L, Ge C, Zeltser R, Maskevitch G, Mayer B, Alexandropoulos K . c-Src signaling induced by the adapters Sin and Cas is mediated by Rap1 GTPase. Mol Cell Biol. 2000; 20(19):7363-77. PMC: 86290. DOI: 10.1128/MCB.20.19.7363-7377.2000. View

4.
Shiozaki A, Kosuga T, Ichikawa D, Komatsu S, Fujiwara H, Okamoto K . XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma. Ann Surg Oncol. 2012; 20(9):3140-50. DOI: 10.1245/s10434-012-2474-4. View

5.
Gillingham A, Munro S . Long coiled-coil proteins and membrane traffic. Biochim Biophys Acta. 2003; 1641(2-3):71-85. DOI: 10.1016/s0167-4889(03)00088-0. View